New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Reata Pharmaceuticals, Inc.
RETA
Shape
US Flag

NASDAQ

7B

Biotechnology

172.36USD
Shape0.04 ( 0.02%)
favorite-chart

Relative Strenght

99
favorite-chart

Volume Buzz

100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

0%

Quote Panel

Shape
Updated October 18, 2024
1W % 1M % 3M % 1Y %

Key Metrics

Shape
  • Market Cap

    6.57B


  • Shares Outstanding

    38.10M


  • Share in Float

    29.79M


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    172.36


  • Average Volume

    954093


  • Beta

    1.419432


  • Range

    21.83-172.46


  • Industry

    Biotechnology


  • Website

    https://www.reatapharma.com


  • Sector

    Healthcare


Fundamentals

Shape

32.58x

P/E Ratio

269.17x

P/S Ratio

81.96x

P/B Ratio

1.9

Debt/Equity

-328.2%

Net Margin

$-2.6

EPS

How RETA compares to sector?

P/E Ratio

Relative Strength

Shape

RETA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Guggenheim

initialise

Previous: Not converted

2023-06-12

Now: Buy

MoffettNathanson

upgrade

Previous: Not converted

2023-06-12

Now: Outperform

Barclays

initialise

Previous: Not converted

2021-04-28

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.21

arrow
arrow

+109%

1.86
vs 0.89

Q2.21

arrow
arrow

-1%

2
vs 2.03

Q3.21

arrow
arrow

+2%

1.97
vs 1.94

Q4.21

arrow
arrow

+24%

2.35
vs 1.9

Q1.22

arrow
arrow

+9%

2.03
vs 1.86

Q2.22

arrow
arrow

+1%

2.02
vs 2

Q3.22

arrow
arrow

+10%

2.16
vs 1.97

Q4.22

arrow
arrow

N/A

-2.33
vs 2.35

Q1.23

arrow
arrow

+55%

3.14
vs 2.03

Q2.23

arrow
arrow

+15%

2.32
vs 2.02

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.21

arrow
arrow

-30%

944K  vs 1.4M

Q2.21

arrow
arrow

-28%

2.2M  vs 3.1M

Q3.21

arrow
arrow

+428%

7.4M  vs 1.4M

Q4.21

arrow
arrow

-71%

934K  vs 3.2M

Q1.22

arrow
arrow

-3%

914K  vs 944K

Q2.22

arrow
arrow

-66%

762K  vs 2.2M

Q3.22

arrow
arrow

-93%

540K  vs 7.4M

Q4.22

arrow
arrow

-2%

914K  vs 934K

Q1.23

arrow
arrow

-79%

195K  vs 914K

Q2.23

arrow
arrow

+2885%

22.7M  vs 762K

Return on EquityShape

status-upQoQ

Q3.21

arrow
arrow

-28%

-0.28
vs -0.23

Q4.21

arrow
arrow

+7%

0.07
vs -0.28

Q1.22

arrow
arrow

-58%

-0.58
vs 0.07

Q2.22

arrow
arrow

+5%

0.05
vs -0.58

Q3.22

arrow
arrow

-1700%

-17.00
vs 0.05

Q4.22

arrow
arrow

+130%

1.3
vs -17.00

Q1.23

arrow
arrow

+7%

0.07
vs 1.3

Q2.23

arrow
arrow

+221%

2.21
vs 0.07

Institutionnal OwnershipShape

status-upQoQ

Q4.21

arrow
arrow

163

163
vs 199

-18%

Q1.22

arrow
arrow

164

164
vs 163

1%

Q2.22

arrow
arrow

153

153
vs 164

-7%

Q3.22

arrow
arrow

173

173
vs 153

13%

Q4.22

arrow
arrow

184

184
vs 173

6%

Q1.23

arrow
arrow

231

231
vs 184

26%

Q2.23

arrow
arrow

238

238
vs 231

3%

Q3.23

arrow
arrow

3

3
vs 238

-99%

Earnings Growth

Latest News